New Zealand
4 Vaccines Approved for Use in New Zealand
Protein Subunit
Novavax
Nuvaxovid
Approved in 37 countries
16 trials in 12 countries
Approval Source: ir.novavax.com
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
84 trials in 27 countries
Approval Source: medsafe.govt.nz
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
64 trials in 31 countries
Approval Source: reuters.com
7 in Clinical Trials in New Zealand
Protein Subunit
Jiangsu Rec-Biotechnology Co Ltd
ReCOV
6 trials in 1 country
Protein Subunit
SK Bioscience Co Ltd
GBP510
6 trials in 6 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
64 trials in 31 countries
Inactivated
Valneva
VLA2001
Approved in 3 countries
6 trials in 3 countries
Inactivated
Valneva
VLA2101
Protein Subunit
VaxForm
CoV2-OGEN1
Protein Subunit
Yisheng Biopharma